Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of adding xenon to therapeutic hypothermia in neonates with hypoxic–ischaemic brain injury risk
2009-014260-19Phase 2Completed
- Sponsor
- University Hospitals Bristol and Weston NHS Foundation Trust
- Start
- Mar 2010
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of xenon in hypoxic-ischemic encephalopathy (HIE) and asphyxia neonatorum, sponsored by University Hospitals Bristol and Weston NHS Foundation Trust. Primary endpoints: Feasibility of xenon delivery with cooling and Safety and physiological effects. Started Mar 2010; status: completed.
02
Drugs
xenon
03
Conditions
hypoxic-ischemic encephalopathy (HIE)asphyxia neonatorum
Beyond the preview
Go deeper on 2009-014260-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014260-19.